Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells

Mol Biol Rep. 2021 Jun;48(6):5121-5133. doi: 10.1007/s11033-021-06509-4. Epub 2021 Jun 24.

Abstract

The High-Risk Human Papillomaviruses (HR-HPVs) 16 and 18 are known to cause cervical cancer, which is primarily attributed to E6 and E7 oncoproteins. In addition, recent studies have focused on the vital role of the p130 pocket protein as an oncosuppressor to limit the expression of E2F transcription factors required for cell cycle progression. In view of this, the current study was conducted to investigate the mechanism by which transfection with HPV16/18 E7 leads to the deregulation of the host cell cycle, altering the localisation of p130, and expression of differentiation genes in Human Keratinocytes (HaCaT) cells. Co-immunoprecipitation, Western blot analysis, immunofluorescence microscopy, flow cytometry, quantitative-Polymerase Chain Reaction (qPCR), and the inhibition of p130 by MG132 inhibitor were employed to investigate the loss of p130 and its disruption in HPV 16/18 E7-transfected HaCaT cells. The HPV16- and HPV18-transformed cells, known as CaSki and HeLa, respectively, were also used to complement the ectopic expressions of E7 in HaCaT cells. Normal keratinocytes displayed higher level of p130 expression than HPV-transformed cells. In addition, the immunofluorescence analysis revealed that both HPV 16/18 E7-transfected HaCaT and HPV-transformed cells exhibited higher level of cytoplasmic p130 compared to nuclear p130. A significant increase in the number of S/G2 phase cells in HPV-transformed cells was also recorded since E7 has been shown to stimulate proliferation through the deactivation of Retinoblastoma Protein (pRB)-dependent G1/S checkpoint. Furthermore, the findings recorded the down-regulation of keratinocyte differentiation markers, namely p130, keratin10, and involucrin. The proteasomal degradation of the exported p130 confirmed the cellular localisation pattern of p130, which was commonly observed in cancerous cells. The findings provide strong evidence that the localisation of nuclear p130 nuclear was disrupted by HPV16/18 E7 led to the deregulation of the cell cycle and the impairment of cellular differentiation ultimately lead to cellular transformation.

Keywords: E7 oncoprotein; HR-HPVs; Localisation; Pocket protein.

MeSH terms

  • Alphapapillomavirus / genetics
  • Alphapapillomavirus / pathogenicity
  • Cell Cycle / physiology
  • Cell Differentiation / physiology
  • Cell Division / physiology
  • Cell Line
  • Crk-Associated Substrate Protein / genetics
  • Crk-Associated Substrate Protein / metabolism*
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Female
  • HeLa Cells
  • Human papillomavirus 16 / metabolism
  • Human papillomavirus 16 / pathogenicity
  • Human papillomavirus 18 / metabolism
  • Human papillomavirus 18 / pathogenicity
  • Humans
  • Keratinocytes / metabolism
  • Oncogene Proteins, Viral / genetics
  • Oncogene Proteins, Viral / metabolism*
  • Papillomaviridae / genetics
  • Papillomavirus E7 Proteins / genetics
  • Papillomavirus E7 Proteins / metabolism*
  • Papillomavirus Infections / genetics
  • Repressor Proteins / genetics
  • Retinoblastoma-Like Protein p130 / genetics
  • Transfection
  • Uterine Cervical Neoplasms / metabolism

Substances

  • BCAR1 protein, human
  • Crk-Associated Substrate Protein
  • DNA-Binding Proteins
  • E7 protein, Human papillomavirus type 18
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Repressor Proteins
  • Retinoblastoma-Like Protein p130
  • oncogene protein E7, Human papillomavirus type 16